Search Within

Lauren E Abrey

Formats
  1. Journal Article (181)
  2. Meeting Abstract (92)
  3. Book Section (5)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (125)
  2. Biostatistics Service (51)
  3. Epidemiology and Biostatistics (51)
  4. Population Sciences Research Program (49)
  5. Radiology, Department of (31)
  6. Survivorship Research (30)

More Groups

People
  1. Lisa De Angelis (125)
  2. Andrew Lassman (49)
  3. Katherine Panageas (48)
  4. Antonio Omuro (41)
  5. Fabio Iwamoto (30)
  6. Denise Correa (27)

More People

Years
  1. 2023 (1)
  2. 2020 (2)
  3. 2019 (2)
  4. 2018 (1)
  5. 2017 (1)
  6. 2015 (3)

More Years

Publications
  1. Neuro-Oncology (63)
  2. Journal of Clinical Oncology (57)
  3. Journal of Neuro-Oncology (29)
  4. Cancer (17)
  5. Neurology (11)
  6. International Journal of Radiation Oncology, Biology, Physics (8)

More Publications

Publishers
  1. Oxford University Press (68)
  2. American Society of Clinical Oncology (57)
  3. Springer (40)
  4. Wiley Blackwell (22)
  5. Elsevier Inc. (19)
  6. Lippincott Williams & Wilkins (14)

More Publishers

Results (278)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cognitive functions in primary CNS lymphoma after single or combined modality regimens
    Journal Article

    Correa, D. D.; Shi, W.; Abrey, L. E.; De Angelis, L. M.; Omuro, A. M.; Deutsch, M. B.; Thaler, H. T.
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Multicenter phase II trial of temozolomide (TMZ) and rituximab (RIT) for recurrent primary CNS lymphoma (PCNSL): North American Brain Tumor Consortium (NABTC) study 05-01
    Meeting Abstract

    Nayak, L.; Abrey, L. E.; Drappatz, J.; Gilbert, M. R.; Reardon, D. A.; Lamborn, K.; Wen, P. Y.; Prados, M.; DeAngelis, L. M.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • FLAIR, T1 contrast enhancement, MR perfusion, and FDG PET following hypofractionated stereotactic radiotherapy (HFSRT), bevacizumab (BEV), and temozolomide (TMZ) for glioblastoma (GBM)
    Meeting Abstract

    Grommes, C.; Karimi, S.; Beal, K.; Chan, T. A.; Abrey, L. E.; Gutin, P. H.; Omuro, A. M. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Longitudinal cognitive follow-up in newly diagnosed glioblastoma patients treated with bevacizumab, temozolomide and hypofractionated stereotactic radiotherapy
    Meeting Abstract

    Correa, D. D.; Baser, R.; Beal, K.; Karimi, S.; DeAngelis, L.; Panageas, K.; Barradas, R.; Statucka, M.; Abrey, L.; Gutin, P.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma
    Meeting Abstract

    Omuro, A.; Beal, K.; Correa, D.; Chan, T.; DeAngelis, L.; Gavrilovic, I.; Nolan, C.; Hormigo, A.; Lassman, A. B.; Kaley, T.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Time trends in treatment of anaplastic oligodendroglial tumors
    Meeting Abstract

    Panageas, K. S.; Iwamoto, F. M.; Cloughesy, T. F.; Aldape, K. D.; Rivera, A. L.; Eichler, A. F.; Louis, D. N.; Paleologos, N. A.; Fisher, B. J.; Ashby, L. S.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors
    Meeting Abstract

    Reiner, A. S.; Panageas, K. S.; Iwamoto, F. M.; Cloughesy, T. F.; Aldape, K. D.; Rivera, A. L.; Eichler, A. F.; Louis, D. N.; Paleologos, N. A.; Fisher, B. J.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • A phase i trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma
    Journal Article

    Nghiemphu, P. L.; Wen, P. Y.; Lamborn, K. R.; Drappatz, J.; Robins, H. I.; Fink, K.; Malkin, M. G.; Lieberman, F. S.; Deangelis, L. M.; Torres-Trejo, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas
    Journal Article

    Iwamoto, F. M.; Hottinger, A. F.; Karimi, S.; Riedel, E.; Dantis, J.; Jahdi, M.; Panageas, K. S.; Lassman, A. B.; Abrey, L. E.; Fleisher, M.; more...
    Journal of Neuro-Oncology (2011)

    Fulltext@MSK | Save